Clinical
Trials
- Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination DeficiencyCondition:Prostate CancerMolecule:Pamiparib
- A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous NSCLCCondition:Lung CancerMolecule:Tislelizumab
- A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung CancerCondition:Lung CancerMolecule:Tislelizumab
- A Study of Tislelizumab Versus Chemotherapy as First Line Treatment in Patients With Advanced Esophageal Squamous Cell Carcinoma (ESCC)Condition:Esophageal CancerMolecule:Tislelizumab
- Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction CarcinomaCondition:Gastric Cancer, Esophageal CancerMolecule:Tislelizumab
- Tislelizumab in MSI-H or dMMR Solid TumorsCondition:Advanced solid tumorsMolecule:Tislelizumab
- Pamiparib and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas (PNOC017)Condition:GlioblastomaMolecule:Pamiparib + Temozolomide
- Study of the Safety and Pharmacokinetics of Lifirafenib in Patients With Solid TumorsCondition:Advanced solid tumorsMolecule:Lifirafenib
- Zanubrutinib in Chinese Patients With Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL)Condition:LymphomaMolecule:Zanubrutinib
- A Study Comparing Obinutuzumab and Zanubrutinib Versus Obinutuzumab Alone in Treating R/R Follicular LymphomaCondition:LymphomaMolecule:Zanubrutinib
See All Trials
Clinical trials are an important part of our research and development efforts and help make possible access to safe and potentially life-saving treatments.